Evidence map›Paper›PMID 32122270›Full record

ArticleEmerging microbes & infections2020

Emerging colistin resistance in

Mohammed Elbediwi, Hang Pan, Silpak Biswas, Yan Li, Min Yue

Abstract readLetter
In one paragraph

Article in Emerging microbes & infections, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Genomic and resistome analysis ofOne health (Amsterdam, Netherlands) · 2025
    Article
  4. Article
  5. Antimicrobial resistance ofFrontiers in cellular and infection microbiology · 2025
    Article
  6. Article
  7. Rosmarinic Acid AttenuatesAntioxidants (Basel, Switzerland) · 2024
    Article
  8. Stress response ofCurrent research in food science · 2024
    Article
  9. Non-typhoidalFrontiers in veterinary science · 2024
    Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Prevalence and Genomic Investigation of Multidrug-ResistantAntibiotics (Basel, Switzerland) · 2022
    Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Mohammed ElbediwiInstitute of Preventive Veterinary Sciences and Department of Veterinary Medicine, Zhejiang University College of Animal Sciences, Hangzhou, People's Republic of China.
Hang PanInstitute of Preventive Veterinary Sciences and Department of Veterinary Medicine, Zhejiang University College of Animal Sciences, Hangzhou, People's Republic of China.
Silpak BiswasInstitute of Preventive Veterinary Sciences and Department of Veterinary Medicine, Zhejiang University College of Animal Sciences, Hangzhou, People's Republic of China.
Yan LiInstitute of Preventive Veterinary Sciences and Department of Veterinary Medicine, Zhejiang University College of Animal Sciences, Hangzhou, People's Republic of China.
Min YueInstitute of Preventive Veterinary Sciences and Department of Veterinary Medicine, Zhejiang University College of Animal Sciences, Hangzhou, People's Republic of China.ORCID 0000-0002-6787-0794

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Worldwide emergence of

Indexed as

ColistinDrug Resistance, BacterialHumansSalmonella entericaSalmonella InfectionsColistinantimicrobial resistancecolistin resistancemcr-1Salmonella Newportseafood

Identifiers

PMID32122270
PMCPMC7067173

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.